D. J. Fediuk

发表

Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed‐Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin

V. Sahasrabudhe, D. J. Fediuk, Kyle T. Matschke, 2018, Clinical pharmacology in drug development.

Metabolic Disposition of the Insect Repellent DEET and the Sunscreen Oxybenzone Following Intravenous and Skin Administration in Rats

F. Burczynski, D. J. Fediuk, M. Namaka, 2012, International journal of toxicology.

Pharmacokinetic and toxicological characterization of repellent DEET and sunscreen oxybenzone

D. J. Fediuk, 2011 .

Tissue Deposition of the Insect Repellent DEET and the Sunscreen Oxybenzone From Repeated Topical Skin Applications in Rats

D. J. Fediuk, X. Gu, J. Raizman, 2010, International journal of toxicology.

Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

G. Nucci, R. Boyd, V. Sahasrabudhe, 2020, Clinical Pharmacokinetics.

Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Healthy Japanese and Western Subjects

G. Nucci, V. Sahasrabudhe, D. J. Fediuk, 2021, Clinical pharmacology in drug development.

Population Pharmacokinetic Analyses of Ertugliflozin in Select Ethnic Populations

V. Sahasrabudhe, D. J. Fediuk, Susan Zhou, 2021, Clinical pharmacology in drug development.

Tissue disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and topical administration in rats

F. Burczynski, D. J. Fediuk, M. Namaka, 2011, Biopharmaceutics & drug disposition.

In‐vitro permeation of the Insect repellent N,N‐diethyl‐m‐toluamide (DEET) and the sunscreen oxybenzone

F. Burczynski, D. J. Fediuk, X. Gu, 2004, The Journal of pharmacy and pharmacology.

Evaluation and Comparison of Five Matrix Excipients for the Controlled Release of Acrivastine and Pseudoephedrine

F. Simons, D. J. Fediuk, K. Simons, 2004, Drug development and industrial pharmacy.

Physiologically Based Pharmacokinetic Modeling Framework for Quantitative Prediction of an Herb–Drug Interaction

N. Oberlies, B. Gufford, D. J. Fediuk, 2014, CPT: pharmacometrics & systems pharmacology.

End‐to‐end application of model‐informed drug development for ertugliflozin, a novel sodium‐glucose cotransporter 2 inhibitor

G. Nucci, V. Sahasrabudhe, D. J. Fediuk, 2021, CPT: pharmacometrics & systems pharmacology.

Bioequivalence of Ertugliflozin/Sitagliptin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components

D. J. Fediuk, Kyle T. Matschke, Haihong Shi, 2019, Clinical pharmacology in drug development.

Meta‐Analysis of Noncompartmental Pharmacokinetic Parameters of Ertugliflozin to Evaluate Dose Proportionality and UGT1A9 Polymorphism Effect on Exposure

T. Tensfeldt, J. Marshall, D. J. Fediuk, 2021, Journal of clinical pharmacology.